GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹21 Cr | ₹16 Cr | ₹22 Cr | ₹13 Cr | ₹75 Cr |
What is the latest Contingent Liabilities ratio of GLAND PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹21 Cr |
Mar2024 | ₹16 Cr |
Mar2023 | ₹22 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹75 Cr |
How is Contingent Liabilities of GLAND PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹21 Cr | 37.24 | |
Mar2024 | ₹16 Cr | -29.41 | |
Mar2023 | ₹22 Cr | 72.94 | |
Mar2022 | ₹13 Cr | -82.91 | |
Mar2021 | ₹75 Cr | - |
Compare Contingent Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,621.0 Cr | -1.9% | -5.1% | 13.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | 1.4% | 2.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,125.0 Cr | 7.1% | 8.8% | 10.3% | Stock Analytics | |
CIPLA | ₹125,454.0 Cr | 3.9% | -1.3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,106.0 Cr | -1.3% | -1.3% | 2.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,263.0 Cr | 0.2% | -6% | -4.1% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -1.9% |
-5.1% |
13.4% |
SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses